Callos Andrew bought CYTK
December 22, 2025 · Form 4 insider transaction
Callos Andrew bought 1,588 shares of Cytokinetics, Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 7 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,588
Price
$0.00
Total value
N/A
InsiderCallos Andrew
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateDecember 22, 2025
Filing dateDecember 29, 2025
Shares owned after53,837
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Performance shares earned upon achievement of performance goal. Shares remain subject to 1-year vesting requirement.